Tower Research Capital (TRC)’s Precision BioSciences DTIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.66K | Sell |
872
-628
| -42% | -$2.64K | ﹤0.01% | 4453 |
|
|
2025
Q1 | $7.16K | Sell |
1,500
-2,808
| -65% | -$13.4K | ﹤0.01% | 3975 |
|
|
2024
Q4 | $16.4K | Buy |
4,308
+3,839
| +819% | +$14.6K | ﹤0.01% | 3361 |
|
|
2024
Q3 | $4.2K | Sell |
469
-3,227
| -87% | -$28.9K | ﹤0.01% | 4637 |
|
|
2024
Q2 | $36K | Buy |
3,696
+3,307
| +850% | +$32.2K | ﹤0.01% | 3353 |
|
|
2024
Q1 | $5.28K | Buy |
+389
| New | +$5.28K | ﹤0.01% | 4565 |
|
|
2023
Q4 | – | Sell |
-969
| Closed | -$9.91K | – | 5972 |
|
|
2023
Q3 | $9.91K | Buy |
969
+780
| +413% | +$7.98K | ﹤0.01% | 4167 |
|
|
2023
Q2 | $2.98K | Buy |
189
+186
| +6,200% | +$2.93K | ﹤0.01% | 5105 |
|
|
2023
Q1 | $0 | Sell |
3
-352
| -99% | – | ﹤0.01% | 5901 |
|
|
2022
Q4 | $13K | Sell |
355
-500
| -58% | -$18.3K | ﹤0.01% | 3593 |
|
|
2022
Q3 | $34K | Buy |
855
+600
| +235% | +$23.9K | ﹤0.01% | 3486 |
|
|
2022
Q2 | $12K | Buy |
255
+147
| +136% | +$6.92K | ﹤0.01% | 4275 |
|
|
2022
Q1 | $10K | Sell |
108
-164
| -60% | -$15.2K | ﹤0.01% | 4297 |
|
|
2021
Q4 | $61K | Buy |
272
+93
| +52% | +$20.9K | ﹤0.01% | 2607 |
|
|
2021
Q3 | $62K | Buy |
179
+73
| +69% | +$25.3K | ﹤0.01% | 2779 |
|
|
2021
Q2 | $40K | Sell |
106
-88
| -45% | -$33.2K | ﹤0.01% | 3203 |
|
|
2021
Q1 | $60K | Sell |
194
-529
| -73% | -$164K | ﹤0.01% | 2968 |
|
|
2020
Q4 | $181K | Sell |
723
-712
| -50% | -$178K | 0.01% | 1797 |
|
|
2020
Q3 | $265K | Buy |
1,435
+1,163
| +428% | +$215K | ﹤0.01% | 2294 |
|
|
2020
Q2 | $68K | Buy |
272
+237
| +677% | +$59.3K | ﹤0.01% | 2797 |
|
|
2020
Q1 | $6K | Buy |
+35
| New | +$6K | ﹤0.01% | 2217 |
|
|
2019
Q4 | – | Sell |
-41
| Closed | -$10K | – | 3718 |
|
|
2019
Q3 | $10K | Sell |
41
-15
| -27% | -$3.66K | ﹤0.01% | 2920 |
|
|
2019
Q2 | $22K | Buy |
+56
| New | +$22K | ﹤0.01% | 2113 |
|